[Clinical significance of the pharmacogenetics in psychiatric and neurological syndromes].
The aim of the paper was the presentation of the newest results of studies in pharmacogenetics of psychiatric and neurological syndromes. It was especially emphasized an important role of pharmacogenetics in safe pharmacotherapy of psychiatric and neurological syndromes.
Milejski
P
P
Katedry i Zakładu Farmakologii Klinicznej AM we Wrocławiu.
Orzechowska-Juzwenko
K
K
D000107:Acetylation; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D001927:Brain Diseases / Q000188:drug therapy*; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D010597:Pharmacogenetics; D010641:Phenotype; D011110:Polymorphism, Genetic; D011619:Psychotropic Drugs / Q000627:therapeutic use*
D000929:Antidepressive Agents, Tricyclic; D011619:Psychotropic Drugs